MAPT and tauopathy: To investigate the effects of the R136S mutation in vivo under a disease-relevant condition, we cross-bred isogenic E4-KI and E4-R136S-KI mice with a widely used tauopathy mouse model expressing Tau-P301S (PS19 line)53.